<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Rare Diseases: Early Drug Development and the Role of Pre-Investigational New Drug Application Meetings; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Rare Diseases: Early Drug Development and the Role of Pre-Investigational New Drug Application Meetings; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2018-10-16 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled "Rare Diseases: Early Drug Development and the Role of Pre-Investigational New Drug Application Meetings." The purpose of this draft guidance is to assist sponsors of drug and biological products for the treatment of rare diseases in planning and conducting more efficient and productive pre-investigational new drug application (pre-IND) meetings. Drug development for rare dis...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2018-22435</p>
    <p><strong>Publication Date:</strong> 2018-10-16</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2018/10/16/2018-22435/rare-diseases-early-drug-development-and-the-role-of-pre-investigational-new-drug-application">https://www.federalregister.gov/documents/2018/10/16/2018-22435/rare-diseases-early-drug-development-and-the-role-of-pre-investigational-new-drug-application</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2018-22435</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
